Difference between revisions of "Part:BBa K1744002"

(Created page with "This part is a fully autonomous arabinose killswitch with a kanamycin resistance gene (truncated version) and amilCP. The araC gene is driven by its native promoter. It controls ...")
 
Line 1: Line 1:
 
This part is a fully autonomous arabinose killswitch with a kanamycin resistance gene (truncated version) and amilCP. The araC gene is driven by its native promoter. It controls the expression of vcrx028 (a toxin) through the promoter PBAD. This promoter is inducible with arabinose and can be repressed with glucose (final concentration of 1 and 5%w/v, respectively). vcrx028 is a toxin gene isolated from pVCR94, a conjugative plasmid discovered in the cholera outbreak of 1994 in a Rwanda refugee camp. Then there is amilCP, a chromoprotein isolated from Acropora millepora that serves as a selection marker. Finally, we have the kanamycin resistance gene which is Aph(3’)-I (aminoglycoside 3’-phosphotransferase) and originate from pOK12. It was selected because the coding sequence had a deletion, making the sequence smaller. This is of particular importance for our project because we use this part for recombineering, which is greatly impaired if the length of the cassette used is bigger than 1.5 kb. This part is designed to be used in recombineering experiment to make a clean deletion where no scars such as FRT sites are left from the experiment. To do so, we first delete the target region with our cassette amplified with homology on both sides of the region to delete and then use medium with glucose (to repress the toxin) and with kanamycin 50 µg/mL to select the recombinants. Then, using a fusion PCR of both sides of the deletion, the cassette is removed and we can counterselect with arabinose (which induce the toxin and kills cells that did not recombined with high efficiencies (100% by now)).To minimise the cassette length and maximise the recombination frequencies we recommend using phosphothiolated primers, 80 bp homologies at least on both sides of the targeted region, only use the part of the cassette PBAD-vcrx028-KanR not more and do the recombineering in a cell containing a plasmidic araC expression. Since amilCP’s expression is not strong enough to be visible in a genomic context, amilCP protein production may therefore serve as an easy plasmid detection system to eliminate plasmidic background that could occur during recombineering. The system is designed so it is easy to select the good cells with the correct phenotype and speed up the screening process that is often the longest part of the experiment.
 
This part is a fully autonomous arabinose killswitch with a kanamycin resistance gene (truncated version) and amilCP. The araC gene is driven by its native promoter. It controls the expression of vcrx028 (a toxin) through the promoter PBAD. This promoter is inducible with arabinose and can be repressed with glucose (final concentration of 1 and 5%w/v, respectively). vcrx028 is a toxin gene isolated from pVCR94, a conjugative plasmid discovered in the cholera outbreak of 1994 in a Rwanda refugee camp. Then there is amilCP, a chromoprotein isolated from Acropora millepora that serves as a selection marker. Finally, we have the kanamycin resistance gene which is Aph(3’)-I (aminoglycoside 3’-phosphotransferase) and originate from pOK12. It was selected because the coding sequence had a deletion, making the sequence smaller. This is of particular importance for our project because we use this part for recombineering, which is greatly impaired if the length of the cassette used is bigger than 1.5 kb. This part is designed to be used in recombineering experiment to make a clean deletion where no scars such as FRT sites are left from the experiment. To do so, we first delete the target region with our cassette amplified with homology on both sides of the region to delete and then use medium with glucose (to repress the toxin) and with kanamycin 50 µg/mL to select the recombinants. Then, using a fusion PCR of both sides of the deletion, the cassette is removed and we can counterselect with arabinose (which induce the toxin and kills cells that did not recombined with high efficiencies (100% by now)).To minimise the cassette length and maximise the recombination frequencies we recommend using phosphothiolated primers, 80 bp homologies at least on both sides of the targeted region, only use the part of the cassette PBAD-vcrx028-KanR not more and do the recombineering in a cell containing a plasmidic araC expression. Since amilCP’s expression is not strong enough to be visible in a genomic context, amilCP protein production may therefore serve as an easy plasmid detection system to eliminate plasmidic background that could occur during recombineering. The system is designed so it is easy to select the good cells with the correct phenotype and speed up the screening process that is often the longest part of the experiment.
 +
 +
 +
<partinfo>BBa_K1744001 SequenceAndFeatures</partinfo>

Revision as of 23:58, 14 September 2015

This part is a fully autonomous arabinose killswitch with a kanamycin resistance gene (truncated version) and amilCP. The araC gene is driven by its native promoter. It controls the expression of vcrx028 (a toxin) through the promoter PBAD. This promoter is inducible with arabinose and can be repressed with glucose (final concentration of 1 and 5%w/v, respectively). vcrx028 is a toxin gene isolated from pVCR94, a conjugative plasmid discovered in the cholera outbreak of 1994 in a Rwanda refugee camp. Then there is amilCP, a chromoprotein isolated from Acropora millepora that serves as a selection marker. Finally, we have the kanamycin resistance gene which is Aph(3’)-I (aminoglycoside 3’-phosphotransferase) and originate from pOK12. It was selected because the coding sequence had a deletion, making the sequence smaller. This is of particular importance for our project because we use this part for recombineering, which is greatly impaired if the length of the cassette used is bigger than 1.5 kb. This part is designed to be used in recombineering experiment to make a clean deletion where no scars such as FRT sites are left from the experiment. To do so, we first delete the target region with our cassette amplified with homology on both sides of the region to delete and then use medium with glucose (to repress the toxin) and with kanamycin 50 µg/mL to select the recombinants. Then, using a fusion PCR of both sides of the deletion, the cassette is removed and we can counterselect with arabinose (which induce the toxin and kills cells that did not recombined with high efficiencies (100% by now)).To minimise the cassette length and maximise the recombination frequencies we recommend using phosphothiolated primers, 80 bp homologies at least on both sides of the targeted region, only use the part of the cassette PBAD-vcrx028-KanR not more and do the recombineering in a cell containing a plasmidic araC expression. Since amilCP’s expression is not strong enough to be visible in a genomic context, amilCP protein production may therefore serve as an easy plasmid detection system to eliminate plasmidic background that could occur during recombineering. The system is designed so it is easy to select the good cells with the correct phenotype and speed up the screening process that is often the longest part of the experiment.



Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 1514
    Illegal NheI site found at 1537
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]